These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 13576741)

  • 21. [The significance of the thyroid gland in relation to the inhibition of inflammation by butazolidin].
    STENGER EG
    Arch Int Pharmacodyn Ther; 1959 Sep; 121():297-305. PubMed ID: 13834307
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experimental study of conjunctivitis treated with hydrocortisone, butazolidin and camoquin].
    VILLEGAS DEL CUVILLO G
    Arch Inst Farmacol Exp (Madr); 1961; 13():77-90. PubMed ID: 14037969
    [No Abstract]   [Full Text] [Related]  

  • 23. [Is butazolidin a protective agent against light?].
    Burckhardt W; Duchini P
    Dermatologica; 1966; 133(1):63-5. PubMed ID: 5927361
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the analgesic strength of pyramidon, butazolidin and carisoprodol in comparison with that of aspirin].
    FROMMEL E; FLEURY C; SCHMIDT-GINZKEY J
    Helv Physiol Pharmacol Acta; 1960; 18():109-11. PubMed ID: 13825366
    [No Abstract]   [Full Text] [Related]  

  • 25. [Research on the mechanism of action of phenylbutazone in rheumatic diseases].
    PAUNESCU-PODEANU A; DINU I; GEORGESCU I; STERESCU P
    Probl Reumatol; 1959; 6():57-64. PubMed ID: 24546198
    [No Abstract]   [Full Text] [Related]  

  • 26. [EFFECT OF BUTAZOLIDIN ON THE GASTRIC MUCOSA (ATTEMPTED CLASSIFICATION OF THE MECHANISM OF ULCER FOLLOWING BUTAZOLIDIN THERAPY)].
    GIETKA J
    Pol Arch Med Wewn; 1964; 34():419-26. PubMed ID: 14254502
    [No Abstract]   [Full Text] [Related]  

  • 27. [EFFECT OF BUTAZOLIDIN ON THE GASTRIC MUSA (ATTEMPTED CLARIFICATION OF THE MECHANISM OF ULCER FOLLOWING THE ADMINISTRATION OF BUTAZOLIDIN. II. BEHAVIOR OF MUCOPOLYSACCHARIDES IN THE GASTRIC MUCOSA].
    GIETKA J
    Pol Arch Med Wewn; 1964; 34():555-64. PubMed ID: 14260313
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experimentation with butazolidin; data on its mechanism of action].
    SERRA PERALBA A; BARCELO P
    Rev Esp Reum Enferm Osteoartic; 1957 Jan; 7(1):161-5. PubMed ID: 13506222
    [No Abstract]   [Full Text] [Related]  

  • 29. [Causes of gastrointestinal hemorrhage after administration of Butazolidin with special reference of thrombocyte function].
    Thiele G; Fiedler H
    Z Gesamte Inn Med; 1974 Sep; 29(17):706-8. PubMed ID: 4548612
    [No Abstract]   [Full Text] [Related]  

  • 30. [ACTION OF TANDERIL (OXYPHENBUTAZONE) AND BUTAZOLIDIN (PHENYLBUTAZONE) ON ALLERGIC INFLAMMATION].
    YAMASAKI H; SAIKAWA H; MASADA A
    Arerugi; 1964 Mar; 13():100-7. PubMed ID: 14138410
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hydrochloric acid production of the stomach after butazolidin administration].
    Hemmati A
    Med Welt; 1967 May; 18():1140-3. PubMed ID: 5633815
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiphlogistic action of phenylbutazone in normal and adrenalectomized rats of different ages relation to the 5-hydroxytryptamine blood concentration.
    Kohút A; Nicák A
    Physiol Bohemoslov; 1975; 24(4):369-75. PubMed ID: 125891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antianaphylactic action of phenylbutazone].
    LECOMTE J; HUGUES J
    Arch Int Physiol Biochim; 1957 Feb; 65(1):132-4. PubMed ID: 13412212
    [No Abstract]   [Full Text] [Related]  

  • 34. Gas chromatographic determination of butazolidin (phenylbutazone) in biological fluids.
    Budd RD
    J Chromatogr; 1982 Jul; 243(2):368-71. PubMed ID: 7119073
    [No Abstract]   [Full Text] [Related]  

  • 35. [The action of phenylbutazone on phagocytosis].
    BRUCKNER I
    Probl Reumatol; 1959; 6():41-7. PubMed ID: 24546035
    [No Abstract]   [Full Text] [Related]  

  • 36. [ON THE MECHANISM OF THE ULCEROGENIC EFFECT OF BUTAZOLIDIN].
    CSALAY L; TOTH E
    Acta Med Acad Sci Hung; 1963; 19():199-208. PubMed ID: 14116155
    [No Abstract]   [Full Text] [Related]  

  • 37. [Butazolidin and delta-butazolidin in ambulatory orthopedic practice].
    RICHTER R; SCHOBERTH H
    Med Welt; 1960 Nov; 47():2512-5. PubMed ID: 13741413
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the mechanism of action of the inhibition of regenerative granulation tissue by antiphlogistics and by the exclusion of air].
    RUDAS B
    Arzneimittelforschung; 1962 Apr; 12():386-8. PubMed ID: 14495008
    [No Abstract]   [Full Text] [Related]  

  • 39. The pharmacologic and clinical characteristics of phenylbutazone (butazolidin).
    HEMMING A; KUZELL WC
    Antibiot Chemother (Northfield); 1953 Jun; 3(6):634-44. PubMed ID: 24542691
    [No Abstract]   [Full Text] [Related]  

  • 40. [Medicinal treatment of arthroses. Effects of oxyphenbutazone (Tanderil) compared with phenylbutazone (Butazolidin)].
    GJORUP L
    Ugeskr Laeger; 1963 Jun; 125():863-5. PubMed ID: 13948319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.